Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis–Eligible Population

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae634Source: DataRank Database

Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis–Eligible Population is a research paper published in The Journal of Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.10)OA: hybridTopics (49)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Sanjat Kanjilal ORCID,David Helekal ORCID,Gregory K. Robbins ORCID,Yonatan H. Grad ORCID,Rachel Mittelstaedt ORCID

Live enrichment

PubMed:39718967 PMC:PMC11998573 OpenAlex:https://openalex.org/W4405745747

National Institute of Allergy and Infectious Diseases

Grant: T32 AI007433

National Institute of Allergy and Infectious Diseases

Grant: 200-2016-91779

NIAID NIH HHS

Grant: R01 AI132606

CDC HHS

Centers for Disease Control and Prevention

CDC HHS

FWCI

2.10

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiae634/61272267/jiae634.pdf

publisherhttps://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiae634/61272267/jiae634.pdf

publisherhttps://academic.oup.com/jid/article-pdf/231/4/e708/61272267/jiae634.pdf

journalhttps://doi.org/10.1093/infdis/jiae634

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39718967

Fields of Study

Antimicrobial Resistance in StaphylococcusDrug-Induced Adverse ReactionsAntibiotic Use and ResistanceHumansDoxycyclineMaleAnti-Bacterial AgentsStaphylococcal InfectionsStaphylococcus aureusPost-Exposure ProphylaxisTetracycline ResistanceMiddle AgedDrug Resistance, Multiple, BacterialAdultTrimethoprim, Sulfamethoxazole Drug CombinationMicrobial Sensitivity TestsYoung AdultAged

MeSH Terms

AdultAgedAnti-Bacterial AgentsDoxycyclineHumansMaleMicrobial Sensitivity TestsMiddle AgedStaphylococcal InfectionsStaphylococcus aureusTetracycline ResistanceTrimethoprim, Sulfamethoxazole Drug CombinationDrug Resistance, Multiple, BacterialYoung AdultPost-Exposure Prophylaxis

Keywords

DoxycyclineTetracyclineStaphylococcus aureusClindamycinPopulationTrimethoprimMedicineMicrobiologySulfamethoxazoleDrug resistanceAntibioticsBiologyEnvironmental healthBacteriaDoxy-PepDoxycycline Postexposure Prophylaxis

Sustainable Development Goals

SDG 0: Good health and well-being